You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 10,052,277

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,052,277

Title:	Extended release fragrance compositions
Abstract:	Compositions are provided that provide release of fragrance over an extended period of time. The compositions comprise a hydrophilically-modified cross-linked silicone elastomer and an acrylic rheology modifier.
Inventor(s):	Lull; Michael A. (Pleasantville, NY), McNamara; William E. (Chester, NY), Anderson; Glen T. (Pleasantville, NY)
Assignee:	Avon Products, Inc. (Rye, NY)
Application Number:	15/635,287
Patent Claims:	1. A long-wearing composition for providing extended release of fragrance, said composition comprising: (a) from about 0.5% to about 5% by weight of a hydrophilically-modified cross-linked silicone elastomer; (b) from about 0.5% to about 5% by weight of an acrylic rheology modifier; (c) from about 20% to about 75% by weight of a polyol; (d) from about 20% to about 75% by weight of an alcohol; and (e) from about 2% to about 10% by weight of a fragrance oil, wherein the composition is capable of releasing said fragrance oil over a longer period of time as compared to an otherwise identical composition lacking either said hydrophilically-modified cross-linked silicone elastomer or said acrylic rheology modifier. 2. The composition according to claim 1, wherein said hydrophilically-modified cross-linked silicone elastomer comprises poly(alkylene oxide) chains grafted to a silicone backbone. 3. The composition according to claim 1, wherein said hydrophilically-modified cross-linked silicone elastomer comprises PEG-12 dimethicone/PPG-20 crosspolymer. 4. The composition according to claim 1, wherein said acrylic rheology modifier comprises a copolymer of an acrylate monomer and an acrylamide monomer. 5. The composition according to claim 1, wherein said acrylic rheology modifier comprises hydroxylethyl acrylate/sodium acryloyldimethyltaurate copolymer. 6. The composition according to claim 1, wherein said polyol comprises glycerin and said alcohol comprises ethanol. 7. The composition according to claim 1, wherein said fragrance oil comprises a blend of one or more fragrance oils. 8. The composition according to claim 1, wherein the weight ratio of said hydrophilically-modified cross-linked silicone elastomer and said acrylic rheology modifier is from about 2:1 to about 1:2. 9. The composition according to claim 1, further comprising one or more actives selected from the group consisting of: retinoids, hydroxyl acids, depigmenting agents, botanicals, collagenase inhibitors, elastase inhibitors, sunscreens, anti-perspirants, deodorants, anti-bacterias, and anti-fungals. 10. The composition according to claim 1, further comprising one or more colorants. 11. The method according to claim 1, wherein said surface is a human integument. 12. The composition according to claim 1, wherein the weight ratio of said polyol to said alcohol from about 2:1 to about 1:2.

Details for Patent 10,052,277

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965	⤷ Try a Trial	2034-01-28
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.